We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women.
- Authors
Jian-min Liu; Hong-yan Zhao; Guang Ning; Ying Chen; Lian-zhen Zhang; Li-hao Sun; Yong-ju Zhao; Man-yin Xu; Jia-lun Chen
- Abstract
Abstract To find out which of the following parameters—serum levels of insulin-like growth factor 1 (IGF-1), osteoprotegerin (OPG), leptin, osteocalcin (OC), and urinary excretion of N-terminal telopeptide of type I collagen (NTx), can be used as an early marker for osteopenia/osteoporosis in women diagnosed by dual-energy X-ray absorptiometry (DXA), 282 premenopausal and 222 postmenopausal women aged 20–75 years were investigated by the measurement of bone mineral densities (BMDs) at lumbar spine (LS) and femoral neck (FN) by DXA, together with serum concentrations of IGF-1, OPG, leptin, OC, and urinary NTx. The characteristics of the earliest marker(s) were tested with the receiver operating characteristic (ROC) analysis. The area under the curve (AUC), sensitivity, and specificity parameters were determined. It was revealed that serum levels of IGF-1 and leptin changed the earliest, with both markers significantly decreasing (P P = 0.020), respectively, at age 30. However, in ROC analysis, IGF-1 was the only early parameter that had the capacity to differentiate the low bone mass/osteoporosis women from the normal ones (P P = 0.026), with lower serum levels of IGF-1 (215.1 ± 22.4 vs. 278.8 ± 9.4 ng/ml; P = 0.02) and less lean mass (33.1 ± 0.6 vs. 34.8 ± 0.2 kg; P = 0.010) than the normal ones. After controlling for age, the serum level of IGF-1 had a weak, but still significant, positive correlation with lean mass (r = 0.17, P
- Subjects
OSTEOPOROSIS; PERIMENOPAUSE; BONE diseases; GROWTH factors
- Publication
Journal of Bone & Mineral Metabolism, 2008, Vol 26, Issue 2, p159
- ISSN
0914-8779
- Publication type
Article
- DOI
10.1007/s00774-007-0799-z